Imprint Wealth LLC Takes Position in Lam Research Co. (NASDAQ:LRCX)

Imprint Wealth LLC purchased a new stake in shares of Lam Research Co. (NASDAQ:LRCX) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 297 shares of the semiconductor company’s stock, valued at approximately $249,000.

A number of other hedge funds have also recently made changes to their positions in LRCX. Moneta Group Investment Advisors LLC grew its position in Lam Research by 117,180.9% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 32,822,222 shares of the semiconductor company’s stock worth $13,795,180,000 after acquiring an additional 32,794,236 shares in the last quarter. Norges Bank bought a new stake in Lam Research in the fourth quarter worth $619,226,000. Morgan Stanley lifted its stake in Lam Research by 34.8% in the fourth quarter. Morgan Stanley now owns 1,651,084 shares of the semiconductor company’s stock worth $693,952,000 after purchasing an additional 425,918 shares during the last quarter. International Assets Investment Management LLC lifted its stake in Lam Research by 76,165.7% in the fourth quarter. International Assets Investment Management LLC now owns 318,028 shares of the semiconductor company’s stock worth $249,099,000 after purchasing an additional 317,611 shares during the last quarter. Finally, Cerity Partners LLC lifted its stake in Lam Research by 1,125.6% in the fourth quarter. Cerity Partners LLC now owns 342,139 shares of the semiconductor company’s stock worth $267,984,000 after purchasing an additional 314,224 shares during the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on LRCX shares. Evercore ISI started coverage on shares of Lam Research in a research note on Tuesday. They set an “outperform” rating and a $1,200.00 price objective for the company. Raymond James upped their price objective on shares of Lam Research from $850.00 to $950.00 and gave the company an “outperform” rating in a research note on Thursday, January 25th. TD Cowen upped their price objective on shares of Lam Research from $710.00 to $975.00 and gave the company an “outperform” rating in a research note on Thursday, January 25th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Lam Research in a research note on Thursday, April 11th. They set a “hold” rating and a $1,000.00 price objective for the company. Finally, Mizuho increased their price target on shares of Lam Research from $900.00 to $935.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and an average target price of $875.55.

Insiders Place Their Bets

In related news, Director Abhijit Y. Talwalkar sold 882 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the transaction, the director now directly owns 10,541 shares of the company’s stock, valued at $10,246,168.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Abhijit Y. Talwalkar sold 882 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the transaction, the director now directly owns 10,541 shares of the company’s stock, valued at $10,246,168.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Christina Corrreia sold 647 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $628,903.41. Following the transaction, the chief accounting officer now directly owns 5,541 shares of the company’s stock, valued at $5,386,018.23. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,029 shares of company stock worth $6,559,489. Company insiders own 0.32% of the company’s stock.

Lam Research Trading Up 1.8 %

NASDAQ:LRCX opened at $963.23 on Wednesday. The company’s 50 day moving average price is $944.50 and its 200-day moving average price is $796.73. Lam Research Co. has a 52 week low of $482.74 and a 52 week high of $1,007.39. The company has a quick ratio of 2.02, a current ratio of 3.06 and a debt-to-equity ratio of 0.61. The stock has a market cap of $126.28 billion, a price-to-earnings ratio of 37.25, a PEG ratio of 3.43 and a beta of 1.51.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.06 by $0.46. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. The company had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter last year, the company posted $10.71 earnings per share. The firm’s quarterly revenue was down 28.8% on a year-over-year basis. On average, equities research analysts forecast that Lam Research Co. will post 28.9 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 3rd. Shareholders of record on Wednesday, March 13th were given a $2.00 dividend. The ex-dividend date was Tuesday, March 12th. This represents a $8.00 annualized dividend and a yield of 0.83%. Lam Research’s payout ratio is presently 30.94%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.